Atlas Trials

RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC

Clinical trial NCT02678013 · UNKNOWN

Trial details

NCT number
NCT02678013
Sponsor
Ming Kuang
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2016-02-01
Primary completion
2020-01-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.